BIOMAT Database Logo BIOMAT Database Logo

Overview of thymosin activity. 1978

G D Marshall, and T L Low, and G B Thurman, and S K Hu, and J L Rossio, and G Trivers, and A L Goldstein

Our current research program centers around the biologic and chemical characterization of the family of polypeptides present in thymosin fraction 5. A system of nomenclature has been developed and the peptides are being systematically isolated and chemically characterized. Thymosin fraction 5 and its component parts influence a variety of lymphocyte properties including cyclic nucleotide levels, migration inhibitory factor production, T-dependent antibody production, and expression of certain surface markers. Thymosin is being used in clinical trials to investigate its effects on immunodeficiency diseases, malignant diseases, and autoimmune diseases.

UI MeSH Term Description Entries
D007153 Immunologic Deficiency Syndromes Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral. Antibody Deficiency Syndrome,Deficiency Syndrome, Immunologic,Deficiency Syndromes, Antibody,Deficiency Syndromes, Immunologic,Immunologic Deficiency Syndrome,Immunological Deficiency Syndromes,Antibody Deficiency Syndromes,Deficiency Syndrome, Antibody,Deficiency Syndrome, Immunological,Deficiency Syndromes, Immunological,Immunological Deficiency Syndrome,Syndrome, Antibody Deficiency,Syndrome, Immunologic Deficiency,Syndrome, Immunological Deficiency,Syndromes, Antibody Deficiency,Syndromes, Immunologic Deficiency,Syndromes, Immunological Deficiency
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D006152 Cyclic GMP Guanosine cyclic 3',5'-(hydrogen phosphate). A guanine nucleotide containing one phosphate group which is esterified to the sugar moiety in both the 3'- and 5'-positions. It is a cellular regulatory agent and has been described as a second messenger. Its levels increase in response to a variety of hormones, including acetylcholine, insulin, and oxytocin and it has been found to activate specific protein kinases. (From Merck Index, 11th ed) Guanosine Cyclic 3',5'-Monophosphate,Guanosine Cyclic 3,5 Monophosphate,Guanosine Cyclic Monophosphate,Guanosine Cyclic-3',5'-Monophosphate,3',5'-Monophosphate, Guanosine Cyclic,Cyclic 3',5'-Monophosphate, Guanosine,Cyclic Monophosphate, Guanosine,Cyclic-3',5'-Monophosphate, Guanosine,GMP, Cyclic,Guanosine Cyclic 3',5' Monophosphate,Monophosphate, Guanosine Cyclic
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000242 Cyclic AMP An adenine nucleotide containing one phosphate group which is esterified to both the 3'- and 5'-positions of the sugar moiety. It is a second messenger and a key intracellular regulator, functioning as a mediator of activity for a number of hormones, including epinephrine, glucagon, and ACTH. Adenosine Cyclic 3',5'-Monophosphate,Adenosine Cyclic 3,5 Monophosphate,Adenosine Cyclic Monophosphate,Adenosine Cyclic-3',5'-Monophosphate,Cyclic AMP, (R)-Isomer,Cyclic AMP, Disodium Salt,Cyclic AMP, Monoammonium Salt,Cyclic AMP, Monopotassium Salt,Cyclic AMP, Monosodium Salt,Cyclic AMP, Sodium Salt,3',5'-Monophosphate, Adenosine Cyclic,AMP, Cyclic,Adenosine Cyclic 3',5' Monophosphate,Cyclic 3',5'-Monophosphate, Adenosine,Cyclic Monophosphate, Adenosine,Cyclic-3',5'-Monophosphate, Adenosine,Monophosphate, Adenosine Cyclic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

G D Marshall, and T L Low, and G B Thurman, and S K Hu, and J L Rossio, and G Trivers, and A L Goldstein
Thymosin alpha1: a historical overview.
September 2007, Annals of the New York Academy of Sciences,
G D Marshall, and T L Low, and G B Thurman, and S K Hu, and J L Rossio, and G Trivers, and A L Goldstein
[Modulation of suppressor activity by thymosin].
January 1981, Comptes rendus des seances de la Societe de biologie et de ses filiales,
G D Marshall, and T L Low, and G B Thurman, and S K Hu, and J L Rossio, and G Trivers, and A L Goldstein
Immunomodulating activity of thymosin fraction 5 and thymosin alpha 1 in immunosuppressed mice.
January 1983, Cancer immunology, immunotherapy : CII,
G D Marshall, and T L Low, and G B Thurman, and S K Hu, and J L Rossio, and G Trivers, and A L Goldstein
[Thymosin activity in thymic fibroblast culture fluid].
October 1980, Biulleten' eksperimental'noi biologii i meditsiny,
G D Marshall, and T L Low, and G B Thurman, and S K Hu, and J L Rossio, and G Trivers, and A L Goldstein
Thymosin-like activity in fetal calf serum?
November 1977, Lancet (London, England),
G D Marshall, and T L Low, and G B Thurman, and S K Hu, and J L Rossio, and G Trivers, and A L Goldstein
Thymosin activity in patients with cellular immunodeficiency.
January 1975, The New England journal of medicine,
G D Marshall, and T L Low, and G B Thurman, and S K Hu, and J L Rossio, and G Trivers, and A L Goldstein
[Biological activity of a sterol isolated from thymosin].
January 1974, Ukrains'kyi biokhimichnyi zhurnal,
G D Marshall, and T L Low, and G B Thurman, and S K Hu, and J L Rossio, and G Trivers, and A L Goldstein
Modulation of terminal deoxynucleotidyl transferase activity by thymosin.
December 1981, Molecular and cellular biochemistry,
G D Marshall, and T L Low, and G B Thurman, and S K Hu, and J L Rossio, and G Trivers, and A L Goldstein
Differential activity of thymosin peptides (thymosin fraction 5) on plasma thyrotropin in female rats of different ages.
May 1988, Neuroendocrinology,
G D Marshall, and T L Low, and G B Thurman, and S K Hu, and J L Rossio, and G Trivers, and A L Goldstein
Discrepancy between biological activity of thymosin and its cyclic nucleotide-modulating activity.
January 1982, International archives of allergy and applied immunology,
Copied contents to your clipboard!